CVD combo filed for rare tumor in Japan after push comes to shove
This article was originally published in Scrip
Executive Summary
Pressure from patient groups and the Japan Endocrine Society has led, by way of official channels, to a filing by three firms in Japan for the approval of a combination therapy for pheochromocytoma, a rare form of neuroendocrine tumor.